Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Against Staphylococcus aureus and Bacterial Species Associated with Infections in Cystic Fibrosis Patients
Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Against Staphylococcus aureus and Bacterial Species Associated with Infections in Cystic Fibrosis Patients, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC